Literature DB >> 23238748

Antibody gene transfer for HIV immunoprophylaxis.

Alejandro B Balazs1, Anthony P West.   

Abstract

Antibody gene transfer, which involves the delivery of genes that encode potent, broadly neutralizing antibodies to human immunodeficiency virus (HIV), is a promising new strategy for preventing HIV infection. A satellite symposium at the AIDS Vaccine 2012 conference brought together many of the groups working in this field.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23238748      PMCID： PMC4560170          DOI： 10.1038/ni.2480

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  26 in total

1.  Single-chain Fv-based anti-HIV proteins: potential and limitations.

Authors:  Anthony P West; Rachel P Galimidi; Priyanthi N P Gnanapragasam; Pamela J Bjorkman
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse.

Authors:  Shailesh K Choudhary; Naser L Rezk; William L Ince; Manzoor Cheema; Liguo Zhang; Lishan Su; Ronald Swanstrom; Angela D M Kashuba; David M Margolis
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

3.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

4.  Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Authors:  Laura M Walker; Sanjay K Phogat; Po-Ying Chan-Hui; Denise Wagner; Pham Phung; Julie L Goss; Terri Wrin; Melissa D Simek; Steven Fling; Jennifer L Mitcham; Jennifer K Lehrman; Frances H Priddy; Ole A Olsen; Steven M Frey; Phillip W Hammond; Stephen Kaminsky; Timothy Zamb; Matthew Moyle; Wayne C Koff; Pascal Poignard; Dennis R Burton
Journal:  Science       Date:  2009-09-03       Impact factor: 47.728

5.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

6.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

7.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

Authors:  Amit C Nathwani; Edward G D Tuddenham; Savita Rangarajan; Cecilia Rosales; Jenny McIntosh; David C Linch; Pratima Chowdary; Anne Riddell; Arnulfo Jaquilmac Pie; Chris Harrington; James O'Beirne; Keith Smith; John Pasi; Bertil Glader; Pradip Rustagi; Catherine Y C Ng; Mark A Kay; Junfang Zhou; Yunyu Spence; Christopher L Morton; James Allay; John Coleman; Susan Sleep; John M Cunningham; Deokumar Srivastava; Etiena Basner-Tschakarjan; Federico Mingozzi; Katherine A High; John T Gray; Ulrike M Reiss; Arthur W Nienhuis; Andrew M Davidoff
Journal:  N Engl J Med       Date:  2011-12-10       Impact factor: 176.079

8.  Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1.

Authors:  Zhifeng Sun; Paul W Denton; Jacob D Estes; Florence A Othieno; Bangdong L Wei; Anja K Wege; Michael W Melkus; Angela Padgett-Thomas; Mary Zupancic; Ashley T Haase; J Victor Garcia
Journal:  J Exp Med       Date:  2007-03-26       Impact factor: 14.307

9.  Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys.

Authors:  Philip R Johnson; Bruce C Schnepp; Jianchao Zhang; Mary J Connell; Sean M Greene; Eloisa Yuste; Ronald C Desrosiers; K Reed Clark
Journal:  Nat Med       Date:  2009-05-17       Impact factor: 53.440

10.  Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.

Authors:  Paul W Denton; Jacob D Estes; Zhifeng Sun; Florence A Othieno; Bangdong L Wei; Anja K Wege; Daniel A Powell; Deborah Payne; Ashley T Haase; J Victor Garcia
Journal:  PLoS Med       Date:  2008-01-15       Impact factor: 11.069
View more
  18 in total

Review 1.  The potential of adeno-associated viral vectors for gene delivery to muscle tissue.

Authors:  Dan Wang; Li Zhong; M Abu Nahid; Guangping Gao
Journal:  Expert Opin Drug Deliv       Date:  2014-01-03       Impact factor: 6.648

2.  Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.

Authors:  Kevin O Saunders; Lingshu Wang; M Gordon Joyce; Zhi-Yong Yang; Alejandro B Balazs; Cheng Cheng; Sung-Youl Ko; Wing-Pui Kong; Rebecca S Rudicell; Ivelin S Georgiev; Lijie Duan; Kathryn E Foulds; Mitzi Donaldson; Ling Xu; Stephen D Schmidt; John-Paul Todd; David Baltimore; Mario Roederer; Ashley T Haase; Peter D Kwong; Srinivas S Rao; John R Mascola; Gary J Nabel
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

3.  Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice.

Authors:  Cailin Deal; Alejandro B Balazs; Diego A Espinosa; Fidel Zavala; David Baltimore; Gary Ketner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

Review 4.  In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.

Authors:  Christopher C Nixon; Maud Mavigner; Guido Silvestri; J Victor Garcia
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

Review 5.  Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection.

Authors:  Barna Dey; Edward A Berger
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

Review 6.  State-of-the-art human gene therapy: part I. Gene delivery technologies.

Authors:  Dan Wang; Guangping Gao
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

Review 7.  In vivo platforms for analysis of HIV persistence and eradication.

Authors:  J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

8.  Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic.

Authors:  Mélanie Bouvin-Pley; Marion Morgand; Alain Moreau; Pauline Jestin; Claire Simonnet; Laurent Tran; Cécile Goujard; Laurence Meyer; Francis Barin; Martine Braibant
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

Review 9.  Immunotherapeutic organoids: a new approach to cancer treatment.

Authors:  Marta Compte; Natalia Nuñez-Prado; Laura Sanz; Luís Alvarez-Vallina
Journal:  Biomatter       Date:  2013-01-01

Review 10.  Passive immunization against HIV/AIDS by antibody gene transfer.

Authors:  Lili Yang; Pin Wang
Journal:  Viruses       Date:  2014-01-27       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.